Features Include Online Ordering for Nearly 900 IVD Products
The website, revealed earlier this year, reflects
“Today, customers and prospects can quickly and easily understand how
The new site includes the ability for researchers, IVD test kit manufacturers, and other customers to purchase nearly 900 IVD products online. This provides an added level of convenience for customers to get the critical components they need to develop world-class assays and diagnostic tests.
A recently expanded IVD product line is also showcased on the site, including the newest family of IVD products – the StabilBlot™ Blocker Family. This product family enhances sensitivity and blocks non-specific binding in blotting applications. For customer convenience, they offer product options in bulk and custom dispenses.
Medical device customers seeking specific coating solutions will
appreciate how quickly they can identify the type of medical
coating technology they need—including lubricious, hemocompatible
and drug delivery—and the variety of market
Both the Medical Device and the IVD sections of the website feature video, product information, posters, presentations, white papers, and other useful downloads. The site also provides a glossary, specific to each division, which assists visitors with any unfamiliar terms.
“Our new website was designed to provide responsive, knowledgeable support to our valued customers,” notes Maharaj. “More than ever, they can count on us to help improve the performance of medical devices and diagnostic tests that treat and detect disease.”
SurModics’ mission is to exceed our customers' expectations and enhance
the well-being of patients by providing the world's foremost, innovative
surface modification technologies and in vitro diagnostic
chemical components. The Company partners with the world’s leading and
emerging medical device, diagnostic and life science companies to
develop and commercialize innovative products designed to improve
patient diagnosis and treatment. Core offerings include surface
modification coating technologies that impart lubricity, prohealing, and
biocompatibility capabilities; and components for in vitro
diagnostic test kits and microarrays.
Timothy J. Arens, 952-500-7000
Vice President of Finance and interim Chief Financial Officer